CRIS Current Research Information System

CHIARINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.864
EU - Europa 1.634
AS - Asia 630
AF - Africa 107
SA - Sud America 6
OC - Oceania 3
Totale 4.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.857
IT - Italia 472
GB - Regno Unito 363
SE - Svezia 233
CN - Cina 227
DE - Germania 190
SG - Singapore 154
VN - Vietnam 144
IN - India 69
UA - Ucraina 63
IE - Irlanda 62
RU - Federazione Russa 52
TG - Togo 43
FR - Francia 40
EE - Estonia 35
FI - Finlandia 26
ZA - Sudafrica 26
CH - Svizzera 24
CI - Costa d'Avorio 24
BG - Bulgaria 20
JO - Giordania 17
BE - Belgio 14
NL - Olanda 13
HR - Croazia 9
NG - Nigeria 9
CA - Canada 6
ID - Indonesia 5
SC - Seychelles 5
GR - Grecia 4
BR - Brasile 3
CZ - Repubblica Ceca 3
LT - Lituania 3
TR - Turchia 3
DK - Danimarca 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BS - Bahamas 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 4.244
Salva come PNG Salva come JPEG
Città #
Southend 316
Fairfield 204
Chandler 193
Parma 191
Ashburn 170
Santa Clara 145
Singapore 139
Dong Ket 111
Ann Arbor 97
Wilmington 97
Woodbridge 96
Houston 92
Seattle 87
Princeton 80
Cambridge 73
Bologna 70
Dublin 62
Boardman 52
Lomé 43
Nanjing 33
Westminster 31
Jacksonville 30
Padova 30
Helsinki 25
Abidjan 24
Bremen 23
Berlin 21
Sofia 20
Reggio Emilia 19
Bern 18
Saint Petersburg 18
Amman 17
Turin 17
Beijing 16
Jinan 16
Shenyang 15
Brussels 13
Shanghai 13
Des Moines 12
Florence 12
Nanchang 12
San Diego 11
Abeokuta 9
Changsha 9
Guangzhou 9
Medford 9
Tianjin 9
Washington 9
Hebei 8
Los Angeles 8
New York 8
Hangzhou 7
Redmond 7
Falls Church 6
Milan 6
Moscow 6
Mülheim 6
Ningbo 6
Olalla 6
Redwood City 6
Rome 6
Haikou 5
Jakarta 5
Mahé 5
Mountain View 5
Norwalk 5
Phoenix 5
Toronto 5
Durham 4
Jiaxing 4
London 4
San Francisco 4
Tappahannock 4
Verona 4
Bühl 3
Falkenstein 3
Fuzhou 3
Lausanne 3
Taizhou 3
Urbino 3
Vilnius 3
Wuxi 3
Casalecchio di Reno 2
Cedar Knolls 2
Dearborn 2
Den Haag 2
Ferrara di Monte Baldo 2
Foshan 2
Groningen 2
Hong Kong 2
Istanbul 2
Kuban 2
Kunming 2
Oxford 2
Putignano 2
Rimini 2
San Felice sul Panaro 2
San Ferdinando Di Puglia 2
São Paulo 2
Taiyuan 2
Totale 3.023
Salva come PNG Salva come JPEG
Nome #
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 333
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. 179
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 144
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 142
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 137
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 127
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 123
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. 122
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 122
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 121
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 120
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 120
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 118
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 115
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 114
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 112
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 112
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 110
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis 109
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 107
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. 103
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 103
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells. 102
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 102
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. 94
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml 93
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 90
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 90
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. 86
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 85
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). 77
null 75
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 71
Temsirolimus, An Allosteric mTORC1 Inhibitor, Is Synergistic with Clofarabine in AML and AML Leukemia Initiating Cells 70
null 69
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 65
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients 62
The role played by Wnt/beta-catenin signaling pathway in acute lymphoblastic leukemia. 55
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 52
The unfolded protein response: a novel therapeutic target in acute leukemias. 42
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. 41
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 37
Totale 4.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020554 0 0 0 0 0 77 102 92 127 62 33 61
2020/2021455 84 33 26 11 17 12 6 33 39 22 21 151
2021/2022797 87 24 54 54 68 32 15 64 25 128 140 106
2022/2023928 81 117 47 121 68 76 34 48 157 35 91 53
2023/2024358 19 41 33 42 24 62 13 13 10 38 21 42
2024/2025647 31 113 137 86 218 62 0 0 0 0 0 0
Totale 4.351